GW Pharmaceuticals Plc (GWPH) financial statements (2021 and earlier)

Company profile

Business Address SOVEREIGN HOUSE
HISTON, CAMBRIDGE CB24 9BZ, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
9/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments487537355
Cash and cash equivalents487537355
Receivables71492
Inventory, net of allowances, customer advances and progress billings1298619
Inventory1298619
Other undisclosed current assets422815
Total current assets:730700391
Noncurrent Assets
Finance lease, right-of-use asset 6
Operating lease, right-of-use asset2525
Property, plant and equipment14412882
Intangible assets, net (including goodwill)1377
Goodwill777
Intangible assets, net (excluding goodwill)6  
Deferred income tax assets21 
Other noncurrent assets853
Deferred tax assets, net7
Other undisclosed noncurrent assets 13 
Total noncurrent assets:210183100
TOTAL ASSETS:940882491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15111058
Accounts payable221010
Accrued liabilities1289947
Taxes payable101
Other liabilities981
Total current liabilities:16011859
Noncurrent Liabilities
Long-term debt and lease obligation28272
Finance lease, liability56
Capital lease obligations2
Operating lease, liability2222
Liabilities, other than long-term debt111111
Other liabilities111111
Other undisclosed noncurrent liabilities  4
Total noncurrent liabilities:393917
Total liabilities:19815675
Stockholders' equity
Stockholders' equity attributable to parent741726415
Common stock111
Additional paid in capital1,6901,6321,247
Accumulated other comprehensive loss(54)(69)(75)
Accumulated deficit(896)(838)(757)
Total stockholders' equity:741726415
TOTAL LIABILITIES AND EQUITY:940882491

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
9/30/2018
Revenues52731113
Cost of revenue(38)(131)(6)
Cost of goods and services sold(38)(27)(6)
Gross profit:4901807
Operating expenses(541)(299)(296)
Operating loss:(52)(118)(289)
Nonoperating income (expense)(2)110(1)
Investment income, nonoperating284
Foreign currency transaction loss, before tax(4)(2)(5)
Other nonoperating income 104 
Interest and debt expense(1)(1)(1)
Loss from continuing operations before income taxes:(55)(9)(291)
Income tax expense (benefit)(3)0(4)
Net loss available to common stockholders, diluted:(58)(9)(295)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
9/30/2018
Net loss:(58)(9)(295)
Comprehensive loss:(58)(9)(295)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1510(1)
Comprehensive income (loss), net of tax, attributable to parent:(43)1(296)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: